CB Scientific(CBSC)
$0.030.00 (0.00%)
CBSC
CB Scientific financials statements
$0.03
At close:0.00 (0.00%)
CB Scientific (CBSC) Ratios
14 Followers
CB Scientific Ratios
CBSC's free cash flow for Q1 2026 was $-191.79K. For the 2026 fiscal year, CBSC's free cash flow was increased by $0.00 and operating cash flow was $-191.79K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.22 | 0.21 | 0.26 | 3.21 | 0.63 |
| Quick Ratio | 0.15 | 0.18 | 0.23 | 3.15 | 0.32 |
| Cash Ratio | 0.00 | 0.15 | 0.20 | 2.59 | 0.04 |
| Solvency Ratio | -0.32 | -1.73 | -3.09 | -38.47 | -8.61 |
| Operating Cash Flow Ratio | -0.29 | -1.51 | -1.74 | -4.77 | -1.33 |
| Short-Term Operating Cash Flow Coverage | -1.18 | -59.49 | -11.87 | -17.93 | -1.73 |
| Net Current Asset Value | $ -2.29M | $ -767.81K | $ -501.86K | $ 364.13K | $ -190.49K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.09 | 0.07 | 0.33 | 0.07 | 1.25 |
| Debt-to-Equity Ratio | -0.23 | -0.03 | -0.27 | 0.09 | -2.05 |
| Debt-to-Capital Ratio | -0.31 | -0.03 | -0.36 | 0.08 | 1.95 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Financial Leverage Ratio | -0.22 | -0.47 | -0.81 | 1.34 | -1.64 |
| Debt Service Coverage Ratio | -1.46 | -61.96 | -19.97 | -3.02 | -5.46 |
| Interest Coverage Ratio | -4.57 | -301.53 | -403.75 | -1.21 | -8.55 |
| Debt to Market Cap | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Net Debt to EBITDA | -0.46 | 0.06 | 0.02 | 0.08 | -0.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 48.74% | -97.47% | 69.76% |
| EBIT Margin | -757.45% | -1203.18% | -2550.05% | -6349.19% | -12279.99% |
| EBITDA Margin | -757.45% | -1203.18% | -2549.31% | -6348.38% | -12259.17% |
| Operating Profit Margin | -757.45% | -1181.52% | -2550.71% | -2475.42% | -9071.50% |
| Pretax Profit Margin | -586.64% | -1207.10% | -2556.37% | -8391.92% | -13341.40% |
| Net Profit Margin | -586.64% | -1207.10% | -2556.37% | -8391.92% | -13341.40% |
| Continuous Operations Profit Margin | -586.64% | -1207.10% | -2556.37% | -8391.92% | -13341.40% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 77.45% | 102.16% | 100.22% | 339.01% | 147.07% |
| Return on Assets (ROA) | -181.34% | -542.76% | -691.03% | -969.81% | -1387.79% |
| Return on Equity (ROE) | 39.06% | 253.61% | 558.99% | -1296.63% | 2279.20% |
| Return on Capital Employed (ROCE) | 66.91% | 303.69% | 557.75% | -382.48% | 1592.50% |
| Return on Invested Capital (ROIC) | 97.10% | 316.29% | 759.21% | -351.02% | -1479.30% |
| Return on Tangible Assets | -181.34% | -542.76% | -691.03% | -969.81% | -1390.29% |
| Earnings Yield | -18.14% | -18.84% | -10.28% | -30.23% | -5.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.73 | 28.83 | 21.42 | 0.83 | 2.46 |
| Payables Turnover | 0.00 | 0.00 | 1.76 | 15.28 | 1.06 |
| Inventory Turnover | 0.00 | 0.00 | 1.81 | 16.10 | 0.06 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 636.04 |
| Asset Turnover | 0.31 | 0.45 | 0.27 | 0.12 | 0.10 |
| Working Capital Turnover Ratio | -0.08 | -0.23 | -1.20 | 0.85 | -0.18 |
| Cash Conversion Cycle | 211.19 | 12.66 | 12.10 | 441.06 | 5548.03 |
| Days of Sales Outstanding | 211.19 | 12.66 | 17.04 | 442.27 | 148.50 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 202.12 | 22.68 | 5742.28 |
| Days of Payables Outstanding | 0.00 | 0.00 | 207.06 | 23.89 | 342.75 |
| Operating Cycle | 211.19 | 12.66 | 219.16 | 464.95 | 5890.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.18 | -59.49 | -11.87 | -17.93 | -1.70 |
| Operating Cash Flow to Sales Ratio | -4.17 | -9.22 | -14.40 | -10.40 | -20.43 |
| Free Cash Flow Yield | -12.89% | -14.39% | -5.79% | -3.75% | -0.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.56 | -5.31 | -9.73 | -3.31 | -19.81 |
| Price-to-Sales (P/S) Ratio | 32.35 | 64.08 | 248.69 | 277.62 | 2642.26 |
| Price-to-Book (P/B) Ratio | -2.15 | -13.46 | -54.38 | 42.90 | -451.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.76 | -6.95 | -17.26 | -26.69 | -129.35 |
| Price-to-Operating Cash Flow Ratio | -7.76 | -6.95 | -17.26 | -26.69 | -129.35 |
| Price-to-Earnings Growth (PEG) Ratio | 0.11 | 0.16 | 0.13 | -0.13 | -0.09 |
| Enterprise Value Multiple | -4.73 | -5.26 | -9.74 | -4.29 | -21.65 |
| Enterprise Value | 5.47M | 8.55M | 20.46M | 20.60M | 86.08M |
| EV to EBITDA | -4.73 | -5.26 | -9.74 | -4.29 | -21.65 |
| EV to Sales | 35.84 | 63.30 | 248.25 | 272.55 | 2653.67 |
| EV to Free Cash Flow | -8.60 | -6.86 | -17.23 | -26.21 | -129.91 |
| EV to Operating Cash Flow | -8.60 | -6.86 | -17.23 | -26.21 | -129.91 |
| Tangible Book Value Per Share | -0.01 | -0.00 | -0.00 | 0.01 | -0.00 |
| Shareholders’ Equity Per Share | -0.01 | -0.00 | -0.00 | 0.01 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.01 | -0.02 | -0.07 | -0.06 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.77 | 1.00 | 1.00 | 1.32 | 1.09 |
| Research & Development to Revenue | 0.18 | 3.11 | 5.89 | 0.00 | 0.00 |
| SG&A to Revenue | 8.39 | 9.71 | 25.99 | 23.77 | 91.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.07 | 1.16 | 0.29 | 0.00 |
| Income Quality | 0.71 | 0.76 | 0.56 | 0.12 | 0.15 |
Currency in USD
